Diversity of vanA-type vancomycin-resistant Enterococcus faecium isolated from broilers, poultry slaughterers and hospitalized humans in Greece

Journal of Antimicrobial Chemotherapy

Volumn 67, Issue 8, 2012, Pages 1811-1818

  Tzavaras, I ^a   Siarkou, V I ^a   Zdragas, A ^b   Kotzamanidis, C ^c   Vafeas, G ^b   Bourtzi Hatzopoulou, E ^a   Pournaras, S ^d   Sofianou, D ^e  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b INSTITUTE OF TECHNOLOGY OF AGRICULTURAL PRODUCTS   (Greece)

^c ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^d UNIVERSITY OF THESSALY   (Greece)

^e Aristotle University and Hippokration General Hospital   (Greece)

Author keywords

Antimicrobial resistance; Discriminant analysis; PFGE; VRE

Indexed keywords

AMPICILLIN; TEICOPLANIN; TETRACYCLINE; VANCOMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BROILER; CECUM; ENTEROCOCCAL INFECTION; ENTEROCOCCUS FAECIUM; FECES; GENE IDENTIFICATION; GENETIC VARIABILITY; GREECE; HOSPITAL PATIENT; HUMAN; LIVESTOCK; MINIMUM INHIBITORY CONCENTRATION; NEWBORN; NONHUMAN; POULTRY; PREVALENCE; SLAUGHTERHOUSE; VANA GENE; VANCOMYCIN RESISTANT ENTEROCOCCUS; VANCOMYCIN RESISTANT ENTEROCOCCUS FAECIUM;

ADULT; ANIMALS; BACTERIAL PROTEINS; CARBON-OXYGEN LIGASES; CARRIER STATE; CECUM; CLUSTER ANALYSIS; DNA, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; ENTEROCOCCUS FAECIUM; GRAM-POSITIVE BACTERIAL INFECTIONS; GREECE; HOSPITALIZATION; HUMANS; INFANT, NEWBORN; MEAT; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; POULTRY; VANCOMYCIN RESISTANCE;

EID: 84864513094     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dks166     Document Type: Article

References (47)

1. Patel R. Clinical impact of vancomycin-resistant enterococci. J Antimicrob Chemother 2003; 51 Suppl 3: iii13-21.
2. Bustamante W, Alpizar A, Hernandez S et al. Predominance of vanA genotype among vancomycin-resistant Enterococcus isolates from poultry and swine in Costa Rica. Appl Environ Microbiol 2003; 69: 7414-9.
3. Kruse H, Johansen BK, Rorvik LM et al. The use of avoparcin as a growth promoter and the occurrence of vancomycin-resistant Enterococcus species in Norwegian poultry and swine production. Microb Drug Resist 1999; 5: 135-9.
4. Manson JM, Smith JM, Cook GM. Persistence of vancomycin-resistant enterococci in New Zealand broilers after discontinuation of avoparcin use. Appl Environ Microbiol 2004; 70: 5764-8.
5. Lebreton F, Depardieu F, Bourdon N et al. D-Ala-D-Ser VanN-type transferable vancomycin resistance in Enterococcus faecium. Antimicrob Agents Chemother 2011; 55: 4606-12.
6. Xu X, Lin D, Yan G et al. vanM, a new glycopeptide resistance gene cluster found in Enterococcus faecium. Antimicrob Agents Chemother 2010; 54: 4643-7.
7. Werner G, Coque TM, Hammerum AM et al. Emergence and spread of vancomycin resistance among enterococci in Europe. Euro Surveill 2008; 13: pii=19046.
8. Kuhn I, Iversen A, Finn M et al. Occurrence and relatedness of vancomycin-resistant enterococci in animals, humans, and the environment in different European regions. Appl Environ Microbiol 2005; 71: 5383-90.
9. European Centre for Disease Prevention and Control. Antimicrobial Resistance Surveillance in Europe 2010: Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). http://www.ecdc.europa.eu/en/publications/Publications/1111_SUR_AMR_data.pdf.pdf (21 March 2012, date last accessed).
10. Kalocheretis P, Baimakou E, Zerbala S et al. Dissemination of vancomycin-resistant enterococci among haemodialysis patients in Athens, Greece. J Antimicrob Chemother 2004; 54: 1031-4.
11. Maniatis AN, Pournaras S, Kanellopoulou M et al. Dissemination of clonally unrelated erythromycin- and glycopeptide-resistant Enterococcus faecium isolates in a tertiary Greek hospital. J Clin Microbiol 2001; 39: 4571-4.
12. Protonotariou E, Dimitroulia E, Pournaras S et al. Trends in antimicrobial resistance of clinical isolates of Enterococcus faecalis and Enterococcus faecium in Greece between 2002 and 2007. J Hosp Infect 2010; 75: 225-7.
13. Sofianou D, Pournaras S, Giosi M et al. Substantially increased faecal carriage of vancomycin-resistant enterococci in a tertiary Greek hospital after a 4 year time interval. J Antimicrob Chemother 2004; 54: 251-4.
14. Souli M, Sakka V, Galani I et al. Colonisation with vancomycin- and linezolid-resistant Enterococcus faecium in a university hospital: molecular epidemiology and risk factor analysis. Int J Antimicrob Agents 2009; 33: 137-42.
15. Kotzamanidis C, Zdragas A, Kourelis A et al. Characterization of vanA-type Enterococcus faecium isolates from urban and hospital wastewater and pigs. J Appl Microbiol 2009; 107: 997-1005.
16. Gousia P, Economou V, Sakkas H et al. Antimicrobial resistance of major foodborne pathogens from major meat products. Foodborne Pathog Dis 2011; 8: 27-38.
17. Bruinsma N, Willems RJ, van den Bogaard AE et al. Different levels of genetic homogeneity in vancomycin-resistant and -susceptible Enterococcus faecium isolates from different human and animal sources analyzed by amplified-fragment length polymorphism. Antimicrob Agents Chemother 2002; 46: 2779-83.
18. Stobberingh E, van den Bogaard A, London N et al. Enterococci with glycopeptide resistance in turkeys, turkey farmers, turkey slaughterers, and (sub)urban residents in the south of the Netherlands: evidence for transmission of vancomycin resistance from animals to humans? Antimicrob Agents Chemother 1999; 43: 2215-21.
19. Simonsen GS, Haaheim H, Dahl KH et al. Transmission of VanA-type vancomycin-resistant enterococci and vanA resistance elements between chicken and humans at avoparcin-exposed farms. Microb Drug Resist 1998; 4: 313-8.
20. Domig KJ, Mayer HK, Kneifel W. Methods used for the isolation, enumeration, characterisation and identification of Enterococcus spp. 1. Media for isolation and enumeration. Int J Food Microbiol 2003; 88: 147-64.
21. Texeira LM, Carvalho MGS, Facklam RR. Enterococcus. In: Murray PR, Baron EJ, Jorgensen JH et al., eds. Manual of Clinical Microbiology, 9th edn. Washington, DC: ASM Press, 2007; 1: 430-42.
22. EUCAST. Breakpoint Tables for Interpretation of MICs and Zone Diameters-Version 2.0. http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/Breakpoint_table_v_2.0_120221.pdf (21 March 2012, date last accessed).
23. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Sixteenth Informational Supplement M100-S16. CLSI, Wayne, PA, USA, 2006.
24. Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically- Seventh Edition: Approved Standard M7-A7. CLSI, Wayne, PA, USA, 2006.
25. Depardieu F, Perichon B, Courvalin P. Detection of the van alphabet and identification of enterococci and staphylococci at the species level by multiplex PCR. J Clin Microbiol 2004; 42: 5857-60.
26. Carroll S, Hargreaves M, Goonetilleke A. Sourcing faecal pollution from onsite wastewater treatment systems in surface waters using antibiotic resistance analysis. J Appl Microbiol 2005; 99: 471-82.
27. Vantarakis A, Venieri D, Komninou G et al. Differentiation of faecal Escherichia coli from humans and animals by multiple antibiotic resistance analysis. Lett Appl Microbiol 2006; 42: 71-7.
28. Wiggins BA. Discriminant analysis of antibiotic resistance patterns in fecal streptococci, a method to differentiate human and animal sources of fecal pollution in natural waters. Appl Environ Microbiol 1996; 62: 3997-4002.
29. Turabelidze D, Kotetishvili M, Kreger A et al. Improved pulsed-field gel electrophoresis for typing vancomycin-resistant enterococci. J Clin Microbiol 2000; 38: 4242-5.
30. Tenover FC, Arbeit RD, Goering RV et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33: 2233-9.
31. Kempf I, Hellard G, Perrin-Guyomard A et al. Prevalence of high-level vancomycin-resistant enterococci in French broilers and pigs. Int J Antimicrob Agents 2008; 32: 463-4.
32. SVARM 2010, Swedish Veterinary Antimicrobial Resistance Monitoring. National Veterinary Institute (SVA), Uppsala, Sweden, 2011. http://www.sva.se/upload/Redesign2011/Pdf/Om%20SVA/publikationer/1/Svarm2010.pdf (21 March 2012, date last accessed).
33. Eisner A, Feierl G, Gorkiewicz G et al. High prevalence of VanA-type vancomycin-resistant enterococci in Austrian poultry. Appl Environ Microbiol 2005; 71: 6407-9.
34. Nilsson O, Greko C, Top J et al. Spread without known selective pressure of a vancomycin-resistant clone of Enterococcus faecium among broilers. J Antimicrob Chemother 2009; 63: 868-72.
35. van den Bogaard AE, Willems R, London N et al. Antibiotic resistance of faecal enterococci in poultry, poultry farmers and poultry slaughterers. J Antimicrob Chemother 2002; 49: 497-505.
36. Garcia-Migura L, Pleydell E, Barnes S et al. Characterization of vancomycin-resistant Enterococcus faecium isolates from broiler poultry and pig farms in England and Wales. J Clin Microbiol 2005; 43: 3283-9.
37. Sorum M, Johnsen PJ, Aasnes B et al. Prevalence, persistence, and molecular characterization of glycopeptide-resistant enterococci in Norwegian poultry and poultry farmers 3 to 8 years after the ban on avoparcin. Appl Environ Microbiol 2006; 72: 516-21.
38. del Campo R, Ruiz-Garbajosa P, Sanchez-Moreno MP et al. Antimicrobial resistance in recent fecal enterococci from healthy volunteers and food handlers in Spain: genes and phenotypes. Microb Drug Resist 2003; 9: 47-60.
39. Novais C, Coque TM, Sousa JC et al. Antimicrobial resistance among faecal enterococci from healthy individuals in Portugal. Clin Microbiol Infect 2006; 12: 1131-4.
40. Garcia-Migura L, Liebana E, Jensen LB et al. A longitudinal study to assess the persistence of vancomycin-resistant Enterococcus faecium (VREF) on an intensive broiler farm in the United Kingdom. FEMS Microbiol Lett 2007; 275: 319-25.
41. Johnsen PJ, Osterhus JI, Sletvold H et al. Persistence of animal and human glycopeptide-resistant enterococci on two Norwegian poultry farms formerly exposed to avoparcin is associated with a widespread plasmid-mediated vanA element within a polyclonal Enterococcus faecium population. Appl Environ Microbiol 2005; 71: 159-68.
42. Aarestrup FM, Wegener HC, Collignon P. Resistance in bacteria of the food chain: epidemiology and control strategies. Expert Rev Anti Infect Ther 2008; 6: 733-50.
43. Lauderdale TL, Shiau YR, Wang HY et al. Effect of banning vancomycin analogue avoparcin on vancomycin-resistant enterococci in chicken farms in Taiwan. Environ Microbiol 2007; 9: 819-23.
44. Willems RJ, van Schaik W. Transition of Enterococcus faecium from commensal organism to nosocomial pathogen. Future Microbiol 2009; 4: 1125-35.
45. Willems RJ, Top J, van Den Braak N et al. Host specificity of vancomycin-resistant Enterococcus faecium. J Infect Dis 2000; 182: 816-23.
46. Oh JY, An S, Jin JS et al. Phenotypic and genotypic differences of the vancomycin-resistant Enterococcus faecium isolates from humans and poultry in Korea. J Microbiol 2007; 45: 466-72.
47. Freitas AR, Coque TM, Novais C et al. Human and swine hosts share vancomycin-resistant Enterococcus faecium CC17 and CC5 and Enterococcus faecalis CC2 clonal clusters harboring Tn1546 on indistinguishable plasmids. J Clin Microbiol 2011; 49: 925-31.